vs
STANDARD BIOTOOLS INC.（LAB）与PEOPLES BANCORP OF NORTH CAROLINA INC（PEBK）财务数据对比。点击上方公司名可切换其他公司
PEOPLES BANCORP OF NORTH CAROLINA INC的季度营收约是STANDARD BIOTOOLS INC.的1.1倍（$21.5M vs $19.6M），PEOPLES BANCORP OF NORTH CAROLINA INC净利率更高（30.8% vs -177.4%，领先208.2%），PEOPLES BANCORP OF NORTH CAROLINA INC同比增速更快（5.6% vs -11.5%），PEOPLES BANCORP OF NORTH CAROLINA INC自由现金流更多（$20.0M vs $-23.1M），过去两年PEOPLES BANCORP OF NORTH CAROLINA INC的营收复合增速更高（4.2% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
美国北卡罗来纳州人民银行控股公司是一家区域性银行控股企业，总部位于美国北卡罗来纳州，主要面向当地居民、中小企业及社区机构提供个人与商业银行服务，涵盖存款账户、各类贷款、抵押业务及财富管理解决方案等。
LAB vs PEBK — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $21.5M |
| 净利润 | $-34.7M | $6.6M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 40.7% |
| 净利率 | -177.4% | 30.8% |
| 营收同比 | -11.5% | 5.6% |
| 净利润同比 | -28.8% | 86.4% |
| 每股收益（稀释后） | $-0.09 | $1.21 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $21.5M | ||
| Q3 25 | $19.6M | $21.4M | ||
| Q2 25 | $21.8M | $20.7M | ||
| Q1 25 | $40.8M | $20.0M | ||
| Q4 24 | — | $20.4M | ||
| Q3 24 | $22.1M | $20.5M | ||
| Q2 24 | $22.5M | $20.1M | ||
| Q1 24 | $45.5M | $19.8M |
| Q4 25 | — | $6.6M | ||
| Q3 25 | $-34.7M | $3.7M | ||
| Q2 25 | $-33.5M | $5.2M | ||
| Q1 25 | $-26.0M | $4.3M | ||
| Q4 24 | — | $3.6M | ||
| Q3 24 | $-26.9M | $4.0M | ||
| Q2 24 | $-45.7M | $4.9M | ||
| Q1 24 | $-32.2M | $3.9M |
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
| Q4 25 | — | 40.7% | ||
| Q3 25 | -168.5% | 22.4% | ||
| Q2 25 | -118.1% | 32.2% | ||
| Q1 25 | -80.8% | 28.2% | ||
| Q4 24 | — | 22.5% | ||
| Q3 24 | -120.9% | 26.0% | ||
| Q2 24 | -134.5% | 31.3% | ||
| Q1 24 | -132.2% | 23.9% |
| Q4 25 | — | 30.8% | ||
| Q3 25 | -177.4% | 17.2% | ||
| Q2 25 | -153.7% | 24.9% | ||
| Q1 25 | -63.8% | 21.8% | ||
| Q4 24 | — | 17.5% | ||
| Q3 24 | -122.0% | 19.3% | ||
| Q2 24 | -203.3% | 24.4% | ||
| Q1 24 | -70.6% | 19.9% |
| Q4 25 | — | $1.21 | ||
| Q3 25 | $-0.09 | $0.67 | ||
| Q2 25 | $-0.09 | $0.95 | ||
| Q1 25 | $-0.07 | $0.79 | ||
| Q4 24 | — | $0.65 | ||
| Q3 24 | $-0.07 | $0.72 | ||
| Q2 24 | $-0.12 | $0.89 | ||
| Q1 24 | $-0.27 | $0.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $58.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $157.1M |
| 总资产 | $539.6M | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $58.1M | ||
| Q3 25 | $129.4M | — | ||
| Q2 25 | $158.6M | — | ||
| Q1 25 | $150.9M | — | ||
| Q4 24 | — | $59.3M | ||
| Q3 24 | $210.6M | $73.2M | ||
| Q2 24 | $269.8M | — | ||
| Q1 24 | $287.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
| Q4 25 | — | $157.1M | ||
| Q3 25 | $399.7M | $149.5M | ||
| Q2 25 | $424.5M | $144.0M | ||
| Q1 25 | $454.6M | $138.5M | ||
| Q4 24 | — | $130.6M | ||
| Q3 24 | $489.3M | $136.3M | ||
| Q2 24 | $510.3M | $124.3M | ||
| Q1 24 | $577.3M | $121.1M |
| Q4 25 | — | $1.7B | ||
| Q3 25 | $539.6M | $1.7B | ||
| Q2 25 | $557.0M | $1.7B | ||
| Q1 25 | $579.6M | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | $681.5M | $1.7B | ||
| Q2 24 | $708.7M | $1.7B | ||
| Q1 24 | $777.7M | $1.7B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $21.4M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $20.0M |
| 自由现金流率自由现金流/营收 | -118.1% | 92.7% |
| 资本支出强度资本支出/营收 | 4.5% | 6.6% |
| 现金转化率经营现金流/净利润 | — | 3.22× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $34.9M |
8季度趋势，按日历期对齐
| Q4 25 | — | $21.4M | ||
| Q3 25 | $-22.2M | $4.7M | ||
| Q2 25 | $-20.7M | $5.5M | ||
| Q1 25 | $-30.3M | $5.9M | ||
| Q4 24 | — | $20.6M | ||
| Q3 24 | $-27.9M | $4.9M | ||
| Q2 24 | $-39.0M | $6.7M | ||
| Q1 24 | $-62.5M | $3.7M |
| Q4 25 | — | $20.0M | ||
| Q3 25 | $-23.1M | $4.4M | ||
| Q2 25 | $-22.6M | $5.4M | ||
| Q1 25 | $-35.3M | $5.2M | ||
| Q4 24 | — | $20.0M | ||
| Q3 24 | $-30.1M | $4.7M | ||
| Q2 24 | $-41.0M | $6.6M | ||
| Q1 24 | $-63.3M | $3.5M |
| Q4 25 | — | 92.7% | ||
| Q3 25 | -118.1% | 20.4% | ||
| Q2 25 | -103.6% | 25.9% | ||
| Q1 25 | -86.6% | 25.8% | ||
| Q4 24 | — | 98.0% | ||
| Q3 24 | -136.4% | 22.9% | ||
| Q2 24 | -182.2% | 32.7% | ||
| Q1 24 | -138.9% | 17.9% |
| Q4 25 | — | 6.6% | ||
| Q3 25 | 4.5% | 1.5% | ||
| Q2 25 | 8.7% | 0.5% | ||
| Q1 25 | 12.4% | 3.8% | ||
| Q4 24 | — | 2.9% | ||
| Q3 24 | 10.2% | 1.0% | ||
| Q2 24 | 8.6% | 0.4% | ||
| Q1 24 | 1.7% | 0.6% |
| Q4 25 | — | 3.22× | ||
| Q3 25 | — | 1.27× | ||
| Q2 25 | — | 1.06× | ||
| Q1 25 | — | 1.36× | ||
| Q4 24 | — | 5.78× | ||
| Q3 24 | — | 1.24× | ||
| Q2 24 | — | 1.36× | ||
| Q1 24 | — | 0.93× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
PEBK
暂无分部数据
